Mark Leuchtenberger

Mark Leuchtenberger

Vorsitzender bei NEUROSENSE THERAPEUTICS LTD.

Vermögen: 80 640 $ am 30.04.2024

67 Jahre
Health Technology
Consumer Services
Commercial Services

Ursprung des Netzwerks ersten Grades von Mark Leuchtenberger

EinheitArt der EinheitIndustrie
Wake Forest University
46
College/University Other Consumer Services 46
18
Extinct Biotechnology 18
Public Company Pharmaceuticals: Major 15
Subsidiary Pharmaceuticals: Major 12
9
Holding Company Biotechnology 9
6
Extinct Pharmaceuticals: Major 6
4
Extinct Pharmaceuticals: Major 4
4
Holding Company Pharmaceuticals: Major 4
Public Company Pharmaceuticals: Major 3
2
Extinct Pharmaceuticals: Major 2
Public Company Pharmaceuticals: Major 2
Public Company Pharmaceuticals: Major 2
1
Subsidiary Pharmaceuticals: Major 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Mark Leuchtenberger

UnternehmenSektorVerknüpfte PersonenHauptposition
BIOGEN INC. Pharmaceuticals: Major

James Tobin

Daniel Char

Roy R. Lobb

Caren Deardorf

Ferenc Tracik

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

The University of North Carolina at Charlotte College/University

Scott E. Reed

Donald C. Ingram

Daniel L. Menichella

Michael Batalia

Masters Business Admin

Undergraduate Degree

Masters Business Admin

Corporate Officer/Principal

The Hebrew University of Jerusalem College/University

Elkan R. Gamzu

Oron Yacoby-Zeevi

Dror Brandwein

Nedira Salzman-Frenkel.

Undergraduate Degree

Doctorate Degree

Graduate Degree

Graduate Degree

College/University

William G. Ward

C. Nye

Kim Westmoreland

David N. LaMond

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Graduate Degree

College/University

Neal M. Farber

Thomas Schuetz

Daniel L. Menichella

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

University of Pennsylvania College/University

Andrew J. Schindler

Elkan R. Gamzu

Darryl L. Landis

Masters Business Admin

Doctorate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Garen Bohlin

Mark J. Fitzpatrick

Peter Carlson

Corporate Officer/Principal

Comptroller/Controller/Auditor

Corporate Officer/Principal

Medical/Nursing Services

Andrew J. Schindler

Matthew King

Boris Pasche

Director/Board Member

Director/Board Member

Director/Board Member

Ben-Gurion University of the Negev College/University

Oron Yacoby-Zeevi

Nedira Salzman-Frenkel.

Alon Ben-Noon

Doctorate Degree

Undergraduate Degree

Masters Business Admin

Harvard Business School College/University

H. Culp

James Tobin

Joshua D. Hamermesh

Masters Business Admin

Masters Business Admin

Masters Business Admin

Wake Forest School of Medicine College/University

Matthew King

Mitesh B. Shah

Michael Batalia

Chairman

Director/Board Member

Director/Board Member

Tufts University College/University

Daniel Char

Caren Deardorf

Undergraduate Degree

Undergraduate Degree

General Government

Stephen L. Wallenhaupt

Darryl L. Landis

Corporate Officer/Principal

Director/Board Member

Indiana University College/University

Elizabeth J. Gatewood

Lynn Sadowski Mason

Corporate Officer/Principal

Undergraduate Degree

George Washington University College/University

Jane Brightwell

Anand Varadan

Graduate Degree

Undergraduate Degree

INFINITY PHARMACEUTICALS, INC. Pharmaceuticals: Major

Joshua D. Hamermesh

Colleen Wilson

Corporate Officer/Principal

Human Resources Officer

The University of North Carolina at Chapel Hill College/University

David W. Dupree

Thomas W. Bunn

Undergraduate Degree

Masters Business Admin

AEGERION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Christine Pellizzari

Mark J. Fitzpatrick

General Counsel

Director of Finance/CFO

Investment Managers

Matthew King

Kim Westmoreland

Private Equity Investor

Consultant / Advisor

MERRILL LYNCH PREFERRED CAPITAL TRUST I Major Banks

Adelaide Sink

Thomas W. Bunn

President

Corporate Officer/Principal

Biotechnology

Neal M. Farber

Roy R. Lobb

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Eric M. Gordon

Thomas Schuetz

Chairman

Corporate Officer/Principal

NEURODERM LTD Biotechnology

Revital Mandil–Levin

Oron Yacoby-Zeevi

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

The College of Management Academic Studies College/University

Chaime Orlev

Revital Mandil–Levin

Undergraduate Degree

Masters Business Admin

TEVA PHARMACEUTICAL INDUSTRIES LIMITED Pharmaceuticals: Generic

Rosemary Crane

Ferenc Tracik

Director/Board Member

Corporate Officer/Principal

TETRAPHASE PHARMACEUTICALS, INC. Pharmaceuticals: Major

Garen Bohlin

Eric M. Gordon

Director/Board Member

Director/Board Member

Investment Managers

Vincent J. Miles

Roy R. Lobb

Private Equity Investor

Corporate Officer/Principal

Investment Managers

Matthew King

Kim Westmoreland

Private Equity Investor

Consultant / Advisor

GSK PLC Pharmaceuticals: Major

H. Culp

Eddie J. Gray

Director/Board Member

Corporate Officer/Principal

Medical Specialties

Joshua D. Hamermesh

Colleen Wilson

Corporate Officer/Principal

Human Resources Officer

Pharmaceuticals: Major

H. Culp

Eddie J. Gray

Director/Board Member

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Rosemary Crane

Lynn Sadowski Mason

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Medical/Nursing Services

Matthew King

Kim Westmoreland

Director/Board Member

Chairman

HILLSHIRE BRANDS CO Food: Meat/Fish/Dairy

Daniel M. Delen

Jane Brightwell

Corporate Officer/Principal

Corporate Officer/Principal

CURIS, INC. Biotechnology

James Tobin

George Eldridge

Director/Board Member

Director of Finance/CFO

Pharmaceuticals: Major

Vincent J. Miles

Christopher Guiffre

Director/Board Member

Corporate Officer/Principal

Pharmaceuticals: Major

H. Culp

Eddie J. Gray

Director/Board Member

Sales & Marketing

Pharmaceuticals: Major

Vincent J. Miles

Elkan R. Gamzu

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Wadih Arap

Renata Pasqualini

Founder

Founder

Biotechnology

Wadih Arap

Renata Pasqualini

Founder

Founder

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Vincent J. Miles

Roy R. Lobb

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Louis Kucera

Michael Batalia

Founder

Director/Board Member

Bar-Ilan University College/University

Revital Mandil–Levin

Hagit Binder

Doctorate Degree

Graduate Degree

KARYOPHARM THERAPEUTICS INC. Pharmaceuticals: Major

Garen Bohlin

Anand Varadan

Director/Board Member

Corporate Officer/Principal

REYNOLDS AMERICAN, INC. Tobacco

Andrew J. Schindler

Daniel M. Delen

Chairman

Chief Executive Officer

Williams College College/University

Walter Ogier

Jay Venkatesan

Undergraduate Degree

Undergraduate Degree

Medical Specialties

Charles Iacovou

Kim Westmoreland

Director/Board Member

Director/Board Member

Statistik

International

Vereinigte Staaten 43
Israel 7
Vereinigtes Königreich 3

Sektoral

Health Technology 23
Consumer Services 16
Finance 8
Health Services 3
Consumer Non-Durables 3

Operativ

Director/Board Member 404
Corporate Officer/Principal 238
Independent Dir/Board Member 80
Chief Executive Officer 75
Undergraduate Degree 63
  1. Börse
  2. Insiders
  3. Mark Leuchtenberger
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT